Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus

References

• Kakio Y, Uchida HA, Takeuchi H, et al. Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis. Geriatr Gerontol Int. 2018;18:1597–1602. doi:10.1111/ggi.13534
   Web of Science ®Google Scholar
• Singh S, Sonkar SK, Sonkar GK, Mahdi AA. Diabetic kidney disease: a systematic review on the role of epigenetics as diagnostic and prognostic marker. Diabetes Metab Res Rev. 2019;35(5):e3155. doi:10.1002/dmrr.3155
   PubMed Web of Science ®Google Scholar
• Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895. doi:10.1053/j.ajkd.2017.10.026
   PubMed Web of Science ®Google Scholar
• Jeong KH, Kim JS, Woo JT, et al. Genome-wide association study identifies new susceptibility loci for diabetic nephropathy in Korean patients with type 2 diabetes mellitus. Clin Genet. 2019;96:35–42. doi:10.1111/cge.13538
   Web of Science ®Google Scholar
• Scheithauer TPM, Rampanelli E, Nieuwdorp M, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. doi:10.3389/fimmu.2020.571731
   PubMed Web of Science ®Google Scholar
• Gurung M, Li Z, You H, et al. Role of gut microbiota in type 2 diabetes pathophysiology. E Bio Med. 2020;51:102590. doi:10.1016/j.ebiom.2019.11.051
   Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553–570. doi:10.1161/CIRCRESAHA.120.316242
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–270. doi:10.1038/nrg3182
   PubMed Web of Science ®Google Scholar
• Pickard JM, Zeng MY, Caruso R, Nunez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279:70–89. doi:10.1111/imr.12567
   PubMed Web of Science ®Google Scholar
• Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019;66(3):526–553. doi:10.1007/s12020-019-02103-8
   PubMed Web of Science ®Google Scholar
• Zhaz F, Liu Q, Cao J, et al. A sea cucumber (Holothuria leucospilota) polysaccharide improves the gut microbiome to alleviate the symptoms of type 2 diabetes mellitus in Goto-Kakizaki rats. Food Chem Toxicol. 2019;135:110886. doi:10.1016/j.fct.2019.110886
   Web of Science ®Google Scholar
• Beli E, Prabakaran S, Krishnan P, Evans-Molina C, Grant MB. Loss of diurnal oscillatory rhythms in gut microbiota correlates with changes in circulating metabolites in type 2 diabetic db/db mice. Nutrients. 2019;11(10):2310. doi:10.3390/nu11102310
   Web of Science ®Google Scholar
• Hui S, Liu Y, Chen M, et al. Capsaicin improves glucose tolerance and insulin sensitivity through modulation of the gut microbiota-bile Acid-FXR axis in type 2 Diabetic db/db mice. Mol Nutr Food Res. 2019;63(23):e1900608. doi:10.1002/mnfr.201900608
   PubMed Web of Science ®Google Scholar
• Felizardo RJF, de Almeida DC, Pereira RL, et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109 a-mediated mechanisms. FASEB J. 2019;33:11190–11894. doi:10.1096/fj.201901080R
   Web of Science ®Google Scholar
• Li F, Wang M, Wang J, Li R, Zhang Y. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front Cell Infect Microbiol. 2019;9:206. doi:10.3389/fcimb.2019.00206
   PubMed Web of Science ®Google Scholar
• Collison J. Gut microbiota linked to kidney disease in SLE. Nat Rev Rheumatol. 2019;15:188.
   Google Scholar
• Mafra D, Borges NA, Lindholm B, Stenvinkel P. Mitochondrial dysfunction and gut microbiota imbalance: an intriguing relationship in chronic kidney disease. Mitochondrion. 2019;47:206–209. doi:10.1016/j.mito.2018.11.006
   Web of Science ®Google Scholar
• Ren M, Zhang H, Qi J, et al. An almond-based low carbohydrate diet improves depression and glycometabolism in patients with type 2 diabetes through modulating gut microbiota and GLP-1: a randomized controlled trial. Nutrients. 2020;12(10):3036. doi:10.3390/nu12103036
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9(5):416–431. doi:10.1007/s13238-018-0549-0
   PubMed Web of Science ®Google Scholar
• Seidu S, Barrat J, Khunti K. Clinical update: the important role of dual kidney function testing (ACR and eGFR) in primary care: identification of risk and management in type 2 diabetes. Prim Care Diabetes. 2020;14:370–375. doi:10.1016/j.pcd.2020.02.006
   Web of Science ®Google Scholar
• Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57(1):1–24. doi:10.1007/s00394-017-1445-8
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang H, Wu P, et al. dbCAN-seq: a database of carbohydrate-active enzyme (CAZyme) sequence and annotation. Nucleic Acids Res. 2018;46:D516–D521. doi:10.1093/nar/gkx894
   PubMed Web of Science ®Google Scholar
• Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496–503. doi:10.1016/j.tibtech.2015.06.011
   PubMed Web of Science ®Google Scholar
• Stavropoulou E, Kantartzi K, Tsigalou C, et al. Focus on the gut-kidney axis in health and disease. Front Med. 2020;7:620102. doi:10.3389/fmed.2020.620102
   Web of Science ®Google Scholar
• Salguero MV, MAI A-O, Singh R, Siepmann T, Vasylyeva TL. Dysbiosis of gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019;18:3461–3469. doi:10.3892/etm.2019.7943
   PubMed Web of Science ®Google Scholar
• Dicker AJ, Huang JTJ, Lonergan M, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147:158–167. doi:10.1016/j.jaci.2020.02.040
   PubMed Web of Science ®Google Scholar
• Di Vincenzo A, Tana C, El Hadi H, Pagano C, Vettor R, Rossato M. Antioxidant, anti-inflammatory, and metabolic properties of tocopherols and tocotrienols: clinical implications for vitamin E supplementation in diabetic kidney disease. Int J Mol Sci. 2019;20(20):5101. doi:10.3390/ijms20205101
   PubMed Web of Science ®Google Scholar
• Kimura I, Ichimura A, Ohue-Kitano R, Igarashi M. Free fatty acid receptors in health and disease. Physiol Rev. 2020;100(1):171–210. doi:10.1152/physrev.00041.2018
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119.
   PubMed Web of Science ®Google Scholar
• Li YJ, Chen X, Kwan TK, et al. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31:1267–1281. doi:10.1681/ASN.2019101029
   PubMed Web of Science ®Google Scholar
• Tao S, Li L, Li L, et al. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition. Acta Diabetol. 2019;56:581–592. doi:10.1007/s00592-019-01316-7
   PubMed Web of Science ®Google Scholar
• Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: a common factor in human diseases. Biomed Res Int. 2017;2017:9351507. doi:10.1155/2017/9351507
   PubMed Web of Science ®Google Scholar
• Pryor R, Norvaisas P, Marinos G, et al. Host-microbe-drug-nutrient screen identifies bacterial effectors of metformin therapy. Cell. 2019;178(1299–1312):e1229. doi:10.1016/j.cell.2019.08.003
   Web of Science ®Google Scholar
• Koh A, Molinaro A, Stahlman M, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(947–961):e917. doi:10.1016/j.cell.2018.09.055
   Web of Science ®Google Scholar
• Lin M, Tang SC. Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transplant. 2014;29(4):746–754. doi:10.1093/ndt/gft446
   PubMed Web of Science ®Google Scholar
• Gellai R, Hodrea J, Lenart L, et al. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Am J Physiol Renal Physiol. 2016;311:F1172–F1181. doi:10.1152/ajprenal.00545.2015
   Web of Science ®Google Scholar
• Haltiwanger RS, Blomberg MA, Hart GW. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine: polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem. 1992;267:9005–9013. doi:10.1016/S0021-9258(19)50380-5
   PubMed Web of Science ®Google Scholar
• Alejandro EU, Bozadjieva N, Kumusoglu D, et al. Disruption of O-linked N-acetylglucosamine signaling induces ER stress and beta cell failure. Cell Rep. 2015;13:2527–2538. doi:10.1016/j.celrep.2015.11.020
   Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–1267. doi:10.1126/science.1223813
   PubMed Web of Science ®Google Scholar